Theme leader: Irma Joosten
In the Western world chronic inflammation is among the leading causes of morbidity and mortality.
We aim to understand and control inflammatory disease for the benefit of each individual patient through (i) unraveling the (immune)pathogenesis of inflammatory disease processes; (ii) elucidating the role of tissue specific factors in the regulation of local immunity and inflammation; (iii) identification of druggable targets and biomarkers; (iv) developing clinical grading tools; (v) performing pharmacogenetic and epidemiological studies.
Inflammation; autoinflammation; immune regulation; immunosuppression; innate immunity; adaptive immunity; autoimmunity; immunotherapy, biologics, psoriasis; atopic dermatitis; RA, COPD, Crohn, arthrosis, hereditary inflammatory diseases; rare inflammatory diseases; transplantation; skin; drug development, pharmacogenomics; personalized medicine; genetic (association) studies
Theme Inflammatory diseases in the news:
- Nu.nl 10th January 2017: 'Slecht cholesterol heeft invloed op ernst artrose'